Estradiol Hemihydrate Patent Expiration

Estradiol Hemihydrate was first introduced by Exeltis Usa Inc in its drug Estrasorb on Oct 9, 2003.


Estradiol Hemihydrate Patents

Given below is the list of patents protecting Estradiol Hemihydrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Estrasorb US5629021 Micellar nanoparticles Jan 31, 2015

(Expired)

Exeltis Usa Inc



Estradiol Hemihydrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List